News About: Pharm. Industry
Daewoong Achieves Import of Its BT-Based Treatment, Easyef, to Middle East Market
Daewoong Pharmaceutical announced on December 17th that the company’s next-generation drug, Easyef, has received a marketing permission from Jordan, providing an entry to the Middle East market starting Year 2005.
...
Ilhwa’s Chairman Visions Company’s Leap into First-Class Pharmaceutical Company
From its recent 33rd year anniversary of company foundation, Chairman Park Sang-kyu of Ilhwa Pharmaceuticals expressed his visions for the upcoming challenges and opportunities shared by everyone from top management t...
Continued Increase of Foreign Investment on Domestic Pharmaceutical Industry
The overall pharmaceutical industry shareholdings by foreign investors are steadily rising since Year 2000, when the government began enforcing the separation of dispensary from the medical practices.
The actual sh...
Dong-A, Green Cross Ranked Among Top 10 Companies with SCI Registrations
The Ministry of Education (MOE) recently conducted its analysis on the domestic companies’ R&D activities by counting the instances of research article submissions and their registrations to the Science Citation Index...
LG Life Sciences’ Novel HBV Treatment Proven for Its Efficacy and Safety
LG Life Sciences, Ltd (LGLS) reported the interim results from the current Phase 2 clinical trial of LB80380, regarded as the next generation treatment for hepatitis B virus (HBV) infection. The results were presente...
Domestic Pharmaceutical Company Provides Free Pharmaceutical Supplies
Cho-A Pharmaceutical Co. announced it will provide free pharmaceutical supplies to a local clinic that was recently established to provide medical services for foreign labor workers, who are suffering various stress-r...
More Ethical Generics to Compete With Originals in 2005
The current intensive campaign efforts by the Korea Association of Pharmaceutical Wholesaler (KAPW) to promote domestic ETC first and novel generics will include Pfizer Korea’s Neurontin (gabapentin) and MSD Korea’s P...
Release of Actual Production Data by Domestic Manufacturers
The Korea Pharmaceutical Manufacturers Association (KPMA) recently announced a decision by its members to release the actual production data, starting from Year 2003, in order to better assist the manufacturers in the...
Domestic Pharmaceutical Firms Set Aggressive Growth Plans for Next Year
As the domestic pharmaceutical industry is receiving a number of positive market expectations for the upcoming year, driven by such factors as continued market share increase by ethical generics, potential launchings ...
Taejoon’s Tech Wonders Recognized at RSNA Conference
At the 90th annual Radiological Society of North America (RSNA) Conference, held from November 28th to December 3rd, Taejoon Pharmaceutical achieved $0.85 million USD worth of export agreements and over $5.5 million U...
